The Orlando VA Healthcare System is conducting market research through a sources sought notice to identify qualified DEA-licensed contractors, including SDVOSB/VOSB and other small businesses, capable of providing pharmaceutical reverse distribution and destruction services. The contractor would collect, transport, reverse distribute, and/or destroy controlled (Schedules I–V) and non-controlled medications on a flat-fee basis, with fees not tied to a percentage of credit returns. Required capabilities include scheduled on-site visits at least four times per year, response within 10 business days of COR requests, chain-of-custody and DEA Form 41 documentation, manufacturer return/credit reconciliation, DSCSA compliance, a toll-free and web-based ordering/reporting system, training, and written collection/contingency plans. Performance would occur at OVAHCS facilities in Orlando, Daytona Beach, and Viera, Florida, with historical collection visits of about 4–12 per site per year and monthly or monthly-to-quarterly frequency depending on site. The anticipated period of performance is one base year plus two 12-month option periods, with an anticipated award date around December 2026.